AQST Financials
Aquestive Therapeutics Inc - Financial statements & key metrics
Stock Price
$0.00
Market Cap
$493.02M
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$57.56M
Gross Profit
-
Operating Income
-
Net Income
$-44.14M
EPS (Diluted)
$-0.51
Balance Sheet Highlights
Total Assets
$101.42M
Total Liabilities
$161.58M
Shareholders Equity
-
Cash & Equivalents
-
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-35.76M
CapEx
-
Free Cash Flow
-
Profitability Metrics
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is AQST revenue?
AQST's most recent quarterly revenue was $57.56M. Annual revenue can be calculated by summing the four most recent quarters.
Is AQST profitable?
AQST reported a loss of $44.14M in the most recent quarter.
What is AQST market cap?
AQST has a market capitalization of $493.02M, making it a small-cap stock.
Does AQST have debt?
View AQST's balance sheet for debt information.
What is AQST cash flow?
Cash flow data is available in the full financial statements.